BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2428029)

  • 21. False elevations of human chorionic gonadotropin associated to iatrogenic hypogonadism in gonadal germ cell tumors.
    Germa JR; Arcusa A; Casamitjana R
    Cancer; 1987 Nov; 60(10):2489-93. PubMed ID: 2444325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
    Nisselbaum JS; Bosl GJ; Golbey RB; Schwartz DC; Schwartz MK
    Ann Clin Lab Sci; 1984; 14(3):179-88. PubMed ID: 6203466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ cell function and hormonal status in patients with testicular cancer.
    Hansen PV; Trykker H; Andersen J; Helkjaer PE
    Cancer; 1989 Aug; 64(4):956-61. PubMed ID: 2545331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
    Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
    J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract]   [Full Text] [Related]  

  • 28. Associations of preorchiectomy hormone levels to testicular germ cell tumor pathology, clinical stage, and size.
    Pineault KG; Cheaib JG; Herati AS; Pierorazio PM
    Asian J Androl; 2021; 23(2):224-226. PubMed ID: 32567579
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S; Arakawa S; Masuda M; Hamami G; Shimatani N; Itho N; Nakatsuka E; Fujii A; Ohono S; Ishigami J; Yoshimoto Y; Hattori M; Fujita T; Okada S
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):352-62. PubMed ID: 6157042
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histopathology of testicular germ cell tumors].
    Morinaga S; Sasano N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum alpha fetoprotein and testicular tumors.
    N Engl J Med; 1977 Mar; 296(12):693-4. PubMed ID: 65733
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
    de Bruijn HW; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Marrink J; Ockhuizen T
    Cancer; 1985 Feb; 55(4):829-35. PubMed ID: 2578303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tumor marker in urology].
    Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
    Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
    Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
    Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High level of beta hCG in spermatic vein of patients with seminoma.
    Fiet J; Jardin A; Guechot J; Villette JM
    Lancet; 1983 Nov; 2(8360):1195. PubMed ID: 6139549
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N
    Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.